125 related articles for article (PubMed ID: 30820788)
41. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
[TBL] [Abstract][Full Text] [Related]
42. MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography.
Shimamoto T; Tani M; Kawai M; Hirono S; Ina S; Miyazawa M; Shimizu A; Uchiyama K; Yokoyama S; Tsutsumi M; Yamaue H
Pancreas; 2010 Aug; 39(6):879-83. PubMed ID: 20357691
[TBL] [Abstract][Full Text] [Related]
43. Exocrine pancreatic function studies, duodenal cytology, and hypotonic duodenography in the diagnosis of surgical jaundice.
Bourke JB; Swann JC; Brown CL; Ritchie HD
Lancet; 1972 Mar; 1(7751):605-8. PubMed ID: 4110312
[No Abstract] [Full Text] [Related]
44. Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker.
Diamandis EP; Plebani M
Clin Chem Lab Med; 2016 Jan; 54(1):e1-2. PubMed ID: 26389634
[No Abstract] [Full Text] [Related]
45. Biomarkers: The challenge to find biomarkers for the early detection of pancreatic cancer.
Weber C
Nat Rev Gastroenterol Hepatol; 2015 Aug; 12(8):427. PubMed ID: 26170217
[No Abstract] [Full Text] [Related]
46. Measurement of sialylated stage-specific embryonic antigen-1 in pure pancreatic juice for the diagnosis of pancreatic cancer.
Ohta H; Sawabu N; Takemori Y; Kidani H; Wakabayashi T; Satomura Y; Watanabe H; Motoo Y; Okai T; Takahashi H
Int J Pancreatol; 1994 Feb; 15(1):35-41. PubMed ID: 7910839
[TBL] [Abstract][Full Text] [Related]
47. [Biliary and pancreatic excretion of etoposide].
Suda Y; Fujiki T
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1191-6. PubMed ID: 8751809
[TBL] [Abstract][Full Text] [Related]
48. The intraductal secretin test: an adjunct to ERCP.
Gregg JA
Gastrointest Endosc; 1982 Aug; 28(3):199-203. PubMed ID: 7129052
[TBL] [Abstract][Full Text] [Related]
49. [Fiberscopic, direct, selective cytodiagnosis of the pancreatic juice in pancreatic neoplasms].
Goto Y; Umetsu Y; Ishioka K; Koizumi M
Nihon Rinsho; 1980; 38(1):121-6. PubMed ID: 7392205
[No Abstract] [Full Text] [Related]
50. [Computer-aided diagnosis for pancreatic function test (author's transl)].
Thurmayr R; Otte M; Thurmayr R
Langenbecks Arch Chir; 1975 Nov; 339():253-7. PubMed ID: 1107710
[TBL] [Abstract][Full Text] [Related]
51. Age- and disease-related methylation of multiple genes in nonneoplastic duodenum and in duodenal juice.
Matsubayashi H; Sato N; Brune K; Blackford AL; Hruban RH; Canto M; Yeo CJ; Goggins M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):573-83. PubMed ID: 15701843
[TBL] [Abstract][Full Text] [Related]
52. Exosomes released from pancreatic cancer cells enhance angiogenic activities via dynamin-dependent endocytosis in endothelial cells in vitro.
Chiba M; Kubota S; Sato K; Monzen S
Sci Rep; 2018 Aug; 8(1):11972. PubMed ID: 30097593
[TBL] [Abstract][Full Text] [Related]
53. Functions and clinical implications of exosomes in pancreatic cancer.
Qian L; Yu S; Chen Z; Meng Z; Huang S; Wang P
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):75-84. PubMed ID: 30419313
[TBL] [Abstract][Full Text] [Related]
54. Comparative proteomic analysis of human pancreatic juice: methodological study.
Zhou L; Lu Z; Yang A; Deng R; Mai C; Sang X; Faber KN; Lu X
Proteomics; 2007 Apr; 7(8):1345-55. PubMed ID: 17443640
[TBL] [Abstract][Full Text] [Related]
55. Exosomes and the Future of Immunotherapy in Pancreatic Cancer.
Batista IA; Melo SA
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699928
[TBL] [Abstract][Full Text] [Related]
56. Pancreatic juice cytology of serous cystic neoplasms communicating with the pancreatic duct: diagnostic pitfalls in this rare entity.
Nagata S; Nishimura S; Takenaka A; Kubo C; Yoshizawa H; Yuki M; Kitamura M; Takahashi H; Uehara H; Nakanishi K; Ishikawa O; Tomita Y
Cytopathology; 2013 Jun; 24(3):199-201. PubMed ID: 22817665
[No Abstract] [Full Text] [Related]
57. Cancer: Diagnosis by extracellular vesicles.
Théry C
Nature; 2015 Jul; 523(7559):161-2. PubMed ID: 26106856
[No Abstract] [Full Text] [Related]
58. High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions.
Tateishi K; Tada M; Yamagata M; Isayama H; Komatsu Y; Kawabe T; Shiratori Y; Omata M
Gut; 1999 Nov; 45(5):737-40. PubMed ID: 10517912
[TBL] [Abstract][Full Text] [Related]
59. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
[TBL] [Abstract][Full Text] [Related]
60. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
